Addressing issues such as congestive heart failure is important to providing safe care to patients with cancer.

Part 1 yesterday covered key tradeoffs and the first two of four categories of strategies that have been advanced to improve risk adjustment in MA. Part 2 below covers the remaining two types of ...

Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a ...

Deep-learning (DL) radiopathomics models can help predict the presence of vessels encapsulating tumour clusters (VETC) in ...

Sunshine Biopharma Inc. has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA lipid nanoparticle (K1.1-mRNA-LNP) product as a novel therapeutic agent for ...

At HCC, advisors have been largely tasked with putting the pathways model into action and getting more students on a ...

Sunshine Biopharma (SBFM) has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines in a ...